Apogee Therapeutics Inc (APGE)
NASDAQ
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|
USD ($) | |||
Total Assets | 426.42M | 401.4M | 823.66M |
Total Current Assets | 426.42M | 398.41M | 820.61M |
Cash and Equivalents | 188.27M | 118.32M | 485.46M |
Total Non-Current Assets | 0 | 3.37M | 3.05M |
Total Liabilities | 17.18M | 21.49M | 22.18M |
Total Current Liabilities | 17.18M | 20.56M | 21.55M |
Total Non-Current Liabilities | 0 | 933k | 630k |
Common Equity | 0 | 0 | 1,000 |
Retained Earnings | -92.04M | -123.77M | -155.86M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 401.4M |
Total Current Assets | 398.41M |
Cash and Equivalents | 118.32M |
Total Non-Current Assets | 379.91M |
Total Liabilities | 21.49M |
Total Current Liabilities | 20.56M |
Total Non-Current Liabilities | 933k |
Total Equity | 379.91M |
Common Equity | 0 |
Retained Earnings | -123.77M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.